ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,956.06
      0.01%
      US Tech 100
      20,758.40
      0.86%
      Dow Jones
      43,433.12
      0.00%
      Brent Oil
      72.775
      0.63%
      Bitcoin
      86,311.51
      2.66%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV

      6. Idexx Laboratories Inc (I1DX34) Quote

      Idexx Laboratories Inc

      Idexx Laboratories Inc (I1DX34)

      BOV
      516.27
      0.00
      (0.00%)
      Closed February 27 3:55PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      516.27
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      476.97 52 Week Range 575.20
      Market Cap
      42.877B
      Previous Close
      516.27
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      5
      Shares Outstanding
      83,052,000
      Dividend Yield
      -
      PE Ratio
      44.99
      Earnings Per Share (EPS)
      10.17
      Revenue
      3.66B
      Net Profit
      845.04M

      About Idexx Laboratories Inc

      Sector
      In Vitro,in Vivo Diagnostics
      Industry
      In Vitro,in Vivo Diagnostics
      Website
      www.idexx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Idexx Laboratories Inc is listed in the In Vitro,in Vivo Diagnostics sector of the Brazil Bovespa Exchange with ticker I1DX34. The last closing price for Idexx Laboratories was R$516.27. Over the last year, Idexx Laboratories shares have traded in a share price range of R$ 476.97 to R$ 575.20.

      Idexx Laboratories currently has 83,052,000 shares outstanding. The market capitalization of Idexx Laboratories is R$42.88 billion. Idexx Laboratories has a price to earnings ratio (PE ratio) of 44.99.

      Ask ADVFN Intelligence (AI)

      I1DX34 Latest News

      More News
      No news to show yet.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      415.273.04790419162501558.35016523.917DR
      12-32.53-5.92747813411548.8558.3476.975520.39207921DR
      26-0.61-0.11801578703516.88558.3476.9713505.64359043DR
      52-58.73-10.2139130435575575.2476.97122503.22321139DR
      156-6.14-1.17532206504522.41575.2336.663494.64177857DR
      260286.82125.003268686229.45743.87229.4574529.43027655DR

      I1DX34 - Frequently Asked Questions (FAQ)

      What is the current Idexx Laboratories share price?
      The current share price of Idexx Laboratories is R$ 516.27
      How many Idexx Laboratories shares are in issue?
      Idexx Laboratories has 83,052,000 shares in issue
      What is the market cap of Idexx Laboratories?
      The market capitalisation of Idexx Laboratories is BRL 42.88B
      What is the 1 year trading range for Idexx Laboratories share price?
      Idexx Laboratories has traded in the range of R$ 476.97 to R$ 575.20 during the past year
      What is the PE ratio of Idexx Laboratories?
      The price to earnings ratio of Idexx Laboratories is 44.99
      What is the cash to sales ratio of Idexx Laboratories?
      The cash to sales ratio of Idexx Laboratories is 10.39
      What is the reporting currency for Idexx Laboratories?
      Idexx Laboratories reports financial results in USD
      What is the latest annual turnover for Idexx Laboratories?
      The latest annual turnover of Idexx Laboratories is USD 3.66B
      What is the latest annual profit for Idexx Laboratories?
      The latest annual profit of Idexx Laboratories is USD 845.04M
      What is the registered address of Idexx Laboratories?
      The registered address for Idexx Laboratories is CORPORATION TRUST CENTER 1209, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
      What is the Idexx Laboratories website address?
      The website address for Idexx Laboratories is www.idexx.com
      Which industry sector does Idexx Laboratories operate in?
      Idexx Laboratories operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ABCB4Banco ABC Brasil S.A.
      R$ 20.00
      (0.00%)
      		0
      AALR3RAllianca Saude e Participacoes S.A.
      R$ 0.00
      (0.00%)
      		0
      AALR3QAllianca Saude e Participacoes S.A.
      R$ 14.95
      (0.00%)
      		0
      AALR3MAllianca Saude e Participacoes S.A.
      R$ 0.00
      (0.00%)
      		0
      AALR3Allianca Saude e Participacoes S.A.
      R$ 11.80
      (0.00%)
      		0
      ABCB4Banco ABC Brasil S.A.
      R$ 20.00
      (0.00%)
      		0
      AALR3RAllianca Saude e Participacoes S.A.
      R$ 0.00
      (0.00%)
      		0
      AALR3QAllianca Saude e Participacoes S.A.
      R$ 14.95
      (0.00%)
      		0
      AALR3MAllianca Saude e Participacoes S.A.
      R$ 0.00
      (0.00%)
      		0
      AALR3Allianca Saude e Participacoes S.A.
      R$ 11.80
      (0.00%)
      		0
      ABCB4Banco ABC Brasil S.A.
      R$ 20.00
      (0.00%)
      		0
      AALR3RAllianca Saude e Participacoes S.A.
      R$ 0.00
      (0.00%)
      		0
      AALR3QAllianca Saude e Participacoes S.A.
      R$ 14.95
      (0.00%)
      		0
      AALR3MAllianca Saude e Participacoes S.A.
      R$ 0.00
      (0.00%)
      		0
      AALR3Allianca Saude e Participacoes S.A.
      R$ 11.80
      (0.00%)
      		0

      Discussion

      View Full Feed
      Konaploinks Konaploinks 58 seconds ago
      Look Jack! He’s swirling! Kerflumpkbok !
      IONQ
      BlazingStocks BlazingStocks 1 minute ago
      $BURU 8K February 07, 2025
      https://ir.nuburu.net/financials/sec-filings/sec-filings-details/default.aspx?FilingId=18165603
      BURU
      wdereb79 wdereb79 1 minute ago
      Mike Tyson lost to Holyfield twice . . . lol. We need a better analogy. lol.
      FNMA
      UAS-Pro UAS-Pro 1 minute ago
      https://x.com/CyberluxC/status/1895089475258138990
      CYBL
      Trooperstocks Trooperstocks 2 minutes ago
      $CBDW CEO Austen Lambrecht of 1606 Corp. stated, "Our AI solutions will further enhance GPOX's current AI usage to enhance its ability to manage complex logistics, optimize inventory, and deliver valuable insights that will transform the way convenience stores and gas stations operate. This collabor
      CBDW GPOX
      Trooperstocks Trooperstocks 2 minutes ago
      $CBDW CEO Austen Lambrecht of 1606 Corp. stated, "Our AI solutions will further enhance GPOX's current AI usage to enhance its ability to manage complex logistics, optimize inventory, and deliver valuable insights that will transform the way convenience stores and gas stations operate. This collabor
      CBDW GPOX
      glenn1919 glenn1919 2 minutes ago
      BLMZ.............................................................p/m
      BLMZ
      stocktowatch stocktowatch 2 minutes ago
      $PHRRF PharmaTher expects to submit the MINOR AMENDMENT to the CRL by end-February 2025 and expects a new approval date for a Q2-2025 FDA approval of ketamine

      TORONTO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM)
      CRL PHRRF
      surfkast surfkast 3 minutes ago
      Why do you care why anyone is here? This is a strock discussion site.
      SPZI
      MartinLutherKing MartinLutherKing 3 minutes ago
      Do your proper DD brothers and you will see TTX MC-138 is the only FDA Human clinical trial Mi-RNA in the world to destroy metastases and y’all now know it’s worth, A 4M market cap has never been seen in pharma history, this company has been shorted criminally, and management is completely useles
      RNAZ
      OPKOHEALTH2022 OPKOHEALTH2022 3 minutes ago
      “This is the year that the hydrogen bubble pops, especially for transportation, but increasingly for all hydrogen for energy plays. One of the firms on my hydrogen death watch is Plug Power, which has managed to lose $3.12 billion of other people’s money since 2010, about $200 million a year on aver
      PLUG
      stockprofitter stockprofitter 4 minutes ago
      Pulte is for the people..BOOOOOOM!!
      FNMA
      Boat Shoes From Yahoo Boat Shoes From Yahoo 4 minutes ago
      Boom!
      FNMA
      gdog gdog 4 minutes ago
      I do realise however if NLST wins there will be lic fees to bring in revenue...
      NLST
      I am done I am done 4 minutes ago
      $YGT.V $YGTFF Gold Terra Wedge Drilling Progressing Well at High-Grade Gold target,
      https://www.accessnewswire.com/newsroom/en/metals-and-mining/gold-terra-wedge-drilling-progressing-well-at-high-grade-gold-target-campbell-shea-992428
      YGT YGTFF
      Trooperstocks Trooperstocks 5 minutes ago
      $RENB David Weinstein, Chief Executive Officer of Renovaro (Nasdaq: RENB) commented, “We believe this new capital now enables the company to accelerate our focus on revolutionizing healthcare by combining advanced diagnostic and personalized immunotherapy for early diagnosis, better-targeted treatme
      RENB
      uranium-pinto-beans uranium-pinto-beans 5 minutes ago
      CRM
      Stifel trims Salesforce price target, calls after-hours pullback 'overreaction'
      Stifel lowered the firm's price target on Salesforce to $375 from $425 and keeps a Buy rating on the shares. Salesforce delivered quarter-over-quarter CRPO acceleration in Q4, a "bevy of AI disclosur
      CRM
      I am done I am done 5 minutes ago
      $YGT.V $YGTFF Gold Terra Wedge Drilling Progressing Well at High-Grade Gold target,
      https://www.accessnewswire.com/newsroom/en/metals-and-mining/gold-terra-wedge-drilling-progressing-well-at-high-grade-gold-target-campbell-shea-992428
      YGT YGTFF
      Trooperstocks Trooperstocks 5 minutes ago
      $RENB David Weinstein, Chief Executive Officer of Renovaro (Nasdaq: RENB) commented, “We believe this new capital now enables the company to accelerate our focus on revolutionizing healthcare by combining advanced diagnostic and personalized immunotherapy for early diagnosis, better-targeted treatme
      RENB
      OPKOHEALTH2022 OPKOHEALTH2022 5 minutes ago
      “This is the year that the hydrogen bubble pops, especially for transportation, but increasingly for all hydrogen for energy plays. One of the firms on my hydrogen death watch is Plug Power, which has managed to lose $3.12 billion of other people’s money since 2010, about $200 million a year on aver
      FCEL
      walterc walterc 5 minutes ago
      I was on vacation in Spain when he was in Eindhoven this month but I will definitely talk to him in Brussels during the PIC conference in April.
      LWLG
      gdog gdog 6 minutes ago
      Wow that seems huge alto I have no Idea how much weight USIJ carries....
      NLST
      Trooperstocks Trooperstocks 7 minutes ago
      David Weinstein, Chief Executive Officer of Renovaro (Nasdaq: RENB) commented, “We believe this new capital now enables the company to accelerate our focus on revolutionizing healthcare by combining advanced diagnostic and personalized immunotherapy for early diagnosis, better-targeted treatments, a
      RENB

      Your Recent History

      BOV
      I1DX34
      Idexx Laboratories
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads